Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2019-07-25
DOI
10.1080/14787210.2019.1647781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Novel Framework to Compare the Effectiveness of β-lactamase Inhibitors against Extended-Spectrum β-lactamase-producing Enterobacteriaceae
- (2019) Henrietta Abodakpi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia
- (2019) Shampa Das et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Novel β-Lactam Enhancer Zidebactam Augments the In Vivo Pharmacodynamic Activity of Cefepime in a Neutropenic Mouse Lung Acinetobacter baumannii Infection Model
- (2019) S. S. Bhagwat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Multidrug-Resistant Pseudomonas aeruginosa in the Neutropenic Murine Thigh Infection Model
- (2019) Marguerite L. Monogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects
- (2018) Keith A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Avibactam Pharmacokinetic/Pharmacodynamic Targets
- (2018) Wright W. Nichols et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Meropenem, with a novel non-β-lactam β-lactamase Inhibitor, Nacubactam, against Gram-negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
- (2018) Marguerite L. Monogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vivo Efficacy of Relebactam (MK-7655) in Combination with Imipenem/Cilastatin in Murine Infection Models
- (2018) Mary Ann Powles et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination With Imipenem and Cilastatin in Healthy Participants
- (2018) Elizabeth G. Rhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model
- (2018) Jin Wu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae
- (2018) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An update on β-lactamase inhibitor discovery and development
- (2018) Jean-Denis Docquier et al. DRUG RESISTANCE UPDATES
- Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
- (2018) Krisztina M. Papp-Wallace et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases
- (2018) Sadeeq ur Rahman et al. Biomed Research International
- Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
- (2018) Jianguo Li et al. CTS-Clinical and Translational Science
- Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
- (2018) Patrick N. A. Harris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers
- (2018) Richard Dimelow et al. Drugs in research & development
- Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem
- (2018) David C. Griffith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients
- (2018) Gary E. Stein et al. Surgical Infections
- Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis
- (2017) Femke De Velde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
- (2016) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam–β-Lactamase Inhibitor Combinations
- (2016) Rachel L. Soon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in anIn VitroInfection Model
- (2016) Anthony M. Nicasio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitropharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms
- (2016) Sherwin K. B. Sy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
- (2015) William F. Penwell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection
- (2015) Johanna Berkhout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam
- (2015) Renu Singh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetic–pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections
- (2015) Yuta Yokoyama et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Pharmacodynamics of Imipenem in Combination with β-Lactamase Inhibitor MK7655 in a Murine Thigh Model
- (2014) Eleftheria Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model
- (2014) Ken Coleman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models
- (2014) Yuta Yokoyama et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in anIn VitroInfection Model
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane
- (2013) Brian VanScoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients
- (2013) M. Carlier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
- (2013) David E. Ehmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors
- (2012) Pratik Bhagunde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases
- (2011) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic and Pharmacodynamic Modeling of High-Dose Intermittent Ticarcillin-Clavulanate Administration in Pediatric Cystic Fibrosis Patients
- (2011) Jeffery T. Zobell et al. CLINICAL THERAPEUTICS
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sulbactam-containing β-lactamase inhibitor combinations
- (2008) M. Akova CLINICAL MICROBIOLOGY AND INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search